Global Scans · Genetics · Weekly Summary

• [New] In the year 2026, the industry size of CRISPR & cas genes is assessed at USD 5.85 billion. Research Nester
• [New] By 2025, 80% of customer service and support organizations will use generative AI technology in some capacity to enhance agent productivity and customer experience. Passive Secrets
• [New] Generative AI tools, such as ChatGPT, Google Bard, and Anthropic's Claude, are expected to push personalization further in 2025. PMC Media Group
• [New] Backed by strengthened financial resources, Synthego plans to expand its CRISPR product portfolio, including its new GMP-grade SpCas9, eSpOT-ON, and Accubase enzymes, which support therapeutic innovation worldwide. CRISPR Medicine
• [New] Whether you are deploying customer service platforms, logistics optimization tools, vertical applications in healthcare or finance, or general-purpose AI agents, you will most likely need to learn to work across Western and Chinese technology. American Association for Physician Leadership - Inspiri
• [New] Differences in population genetics could be associated with the large discrepancies in the prevalence of severe tinnitus, as for instance in South America. PubMed Central (PMC)
• [New] AI and generative AI technologies will generate collective savings of US$13bn over the next three years. Bizclik Media Ltd
• [New] By 2035: AI may approach artificial general intelligence (AGI) levels, capable of reasoning and decision-making closer to humans. AI of the Decade
• [New] By 2035, AI may approach Artificial General Intelligence (AGI) levels - systems that can reason, learn, and adapt across domains with human-like versatility. AI of the Decade
• [New] By 2035, AI may approach Artificial General Intelligence (AGI) - systems capable of reasoning and adapting across domains like humans. AI of the Decade
• The International Maize and Wheat Improvement Center based in Mexico has been testing genetically engineered wheat, and new facilities partially funded by the Bill and Melinda Gates Foundation will enable further research in GM maize and wheat. GMO Answers
• In recent research, Cornell biologists identified a surprising mechanism that weakens bacteria from within - an insight that could guide the next generation of antibiotics as drug resistance rises worldwide. Cornell Chronicle
• Modeling results indicate that widespread adoption of gene-edited, low-lignin feedstocks could reduce pulping-related GHG emissions by 20-50%, lower chemical and energy consumption, and deliver cost savings exceeding $6 billion annually. International Fiber Journal
• Sanofi has 12 new drug candidates, including Amlitelimab and Frexalimab, as next-generation drugs and aims to achieve annual sales of more than €1 billion by 2030. ABITA LLC&MARKETING JAPAN
• The development of next-generation drugs promoted by Sanofi is attracting a great deal of attention in envisioning the future of medicine for 2030. ABITA LLC&MARKETING JAPAN
• The launch of Sanofi's next-generation drugs will revolutionize the medical landscape. ABITA LLC&MARKETING JAPAN
• Companies like 23andMe are already offering genetic testing kits that provide insights into an individual's health risks and traits. HR Fraternity
• In addition to providing genetic counseling, Amazon offers genetic testing services to its employees, allowing them to uncover hidden health risks and take proactive measures to prevent diseases. HR Fraternity
• If CRISPR Therapeutics AG takes out the full calculated possible swing range there will be an estimated 5.24% move between the lowest and the highest trading price during the day. StockInvest.us
• Opus Genetics reports that a phase 1/2 trial of its investigational gene therapy OPGx-BEST 1 will begin by the end of 2025. PentaVision
• Producers may be surprised to know that there are a lot more opportunities to influence the performance of a bovine through the genetics of the rumen microbes than the actual bovine genome. CNS Media

Last updated: 14 September 2025